Meeting
2023 ASCO Annual Meeting
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
Authors
Augustin Vannier
University of Chicago, Chicago, IL
Augustin Vannier , Asim Dhungana , Fangyuan Zhao , Nan Chen , Sarah Shubeck , Olwen Mary Hahn , Rita Nanda , Nora T. Jaskowiak , Gini F. Fleming , Olufunmilayo I. Olopade , Alexander T. Pearson , Dezheng Huo , Frederick Matthew Howard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 574)
DOI
10.1200/JCO.2023.41.16_suppl.574
Abstract #
574
Poster Bd #
404
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Validation of the RSClin risk calculator using the National Cancer Database (NCDB).
First Author: Frederick Howard
Poster
2019 ASCO Annual Meeting
ADAPTcycle: Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer.
First Author: Nadia Harbeck
First Author: Bent Ejlertsen
Poster
2023 ASCO Annual Meeting
Clinical meaning of stromal tumor infiltrating lymphocytes (sTIL) in luminal early breast cancer.
First Author: Esmeralda García-Torralba